GRACEcast

By Howard (Jack) West, MD

Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Edu... more

Download on the App Store

Download on the App Store

Get it on Google Play

FAQs about GRACEcast:

How many episodes does GRACEcast have?

The podcast currently has 625 episodes available.

GRACEcast episodes:

August 14, 2013 ASCO Lung Cancer Highlights, Part 4: Exploring the Role of Trimodality Therapy for Stage III NSCLC (audio)
Dr. David Gerber, University of Texas-Southwestern, reviews a Swiss study comparing tri-modality therapy with chemoradiation followed by surgery to chemo followed by surgery for stage IIIA NSCLC.
...more
7min
August 13, 2013 ASCO Lung Cancer Highlights, Part 3: Immunotherapy for Stage III NSCLC (video)
Dr. David Gerber, University of Texas-Southwestern, reviews results of the START trial of tecemotide immunotherapy for stage III unresectable NSCLC.
...more
9min
August 13, 2013 ASCO Lung Cancer Highlights, Part 3: Immunotherapy for Stage III NSCLC (audio)
Dr. David Gerber, University of Texas-Southwestern, reviews results of the START trial of tecemotide immunotherapy for stage III unresectable NSCLC.
...more
9min
August 11, 2013 ASCO Lung Cancer Highlights, Part 2: Optimizing Radiation for Stage III NSCLC (video)
Dr. David Gerber, University of Texas-Southwestern, reviews results from RTOG 0617 that help clarify the optimal dose of radiation for stage III unresectable NSCLC.
...more
9min
August 11, 2013 ASCO Lung Cancer Highlights, Part 2: Optimizing Radiation for Stage III NSCLC (audio)
Dr. David Gerber, University of Texas-Southwestern, reviews results from RTOG 0617 that help clarify the optimal dose of radiation for stage III unresectable NSCLC.
...more
9min
August 07, 2013 ASCO Lung Cancer Highlights, Part 1: Introduction to Stage III NSCLC (video)
Dr. David Gerber, University of Texas-Southwestern, reviews the current questions in managing locally advanced NSCLC with chemo/radiation as introduction to key issues addressed in trials from ASCO 2013.
...more
8min
August 07, 2013 ASCO Lung Cancer Highlights, Part 1: Introduction to Stage III NSCLC (audio)
Dr. David Gerber, University of Texas-Southwestern, reviews the current questions in managing locally advanced NSCLC with chemo/radiation as introduction to key issues addressed in trials from ASCO 2013.
...more
8min
August 06, 2013 Dr. Bob Doebele: How Should We Manage Acquired Resistance with a Single Lesion or More Diffuse Progression?
Dr. Bob Doebele from the University of Colorado, offers his insights on how to approach a patient with gradual progression in a single site, especially in the brain, or more multifocal progression after a good initial response to a targeted agent.
...more
3min
August 06, 2013 Dr. Philip Bonomi: Gefitinib and Later Generations of EGFR Inhibitors
Dr. Phil Bonomi, from Rush University, describes the generations of EGFR inhibitors beginning with Gefitinib (Iressa).
...more
2min
July 29, 2013 Dr. David Spigel on "Which molecular marker tests do you seek?"
Dr. David Spigel, Sarah Cannon Cancer Center, describes which molecular markers he seeks for NSCLC patients.
...more
1min

FAQs about GRACEcast:

How many episodes does GRACEcast have?

The podcast currently has 625 episodes available.